Adaptive designs for normal responses with prognostic factors
From MaRDI portal
Publication:2775636
DOI10.1093/biomet/88.2.409zbMath0984.62054OpenAlexW2086805881MaRDI QIDQ2775636
Atanu Biswas, Uttam Bandyopadhyay
Publication date: 14 May 2002
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/88.2.409
efficiencyclinical trialsbalanced designbiased coin designlimiting proportion of allocationprobit link
Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05)
Related Items (43)
A simple solution to the inadequacy of asymptotic likelihood-based inference for response-adaptive clinical trials: likelihood-based inference for RAR trials ⋮ Exact statistical power for response adaptive designs ⋮ An adaptive allocation for continuous response using Wilcoxon-Mann-Whitney score ⋮ A new inferential approach for response-adaptive clinical trials: the variance-stabilized bootstrap ⋮ An adaptive design for clinical trials with non-dichotomous response and prognostic factors ⋮ Covariate‐adjusted response adaptive designs incorporating covariates with and without treatment interactions ⋮ Asymptotic properties of covariate-adjusted response-adaptive designs ⋮ Sequential and Two-Stage Fixed-Width Confidence Interval Estimation in Response-Adaptive Designs ⋮ A new design strategy for hypothesis testing under response adaptive randomization ⋮ Optimal response and covariate-adaptive biased-coin designs for clinical trials with continuous multivariate or longitudinal responses ⋮ Missing responses in adaptive allocation design ⋮ Nonparametric testing under crossover design for ordered categorical response ⋮ Longitudinal covariate-adjusted response-adaptive randomized designs ⋮ Nonparametric homogeneity test based on ridit reliability functional ⋮ A randomized two stage allocation for continuous response clinical trials ⋮ A general characterization of optimal tie-breaker designs ⋮ A new response-adaptive design for continuous treatment responses for phase III clinical trials ⋮ A numerical study for comparing two response-adaptive designs for continuous treatment effects ⋮ Handling covariates in the design of clinical trials ⋮ Randomized allocation procedure for testing a normal mean with known variance. ⋮ A sequential design for a clinical trial with a linear prognostic factor ⋮ On binary longitudinal mixed models in adaptive clinical trials ⋮ Fixed-width confidence interval for covariate-adjusted response-adaptive designs ⋮ Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses ⋮ Nonparametric covariate-adjusted response-adaptive design based on a functional urn model ⋮ Inference in Targeted Group‐Sequential Covariate‐Adjusted Randomized Clinical Trials ⋮ Multi-objective optimal designs in comparative clinical trials with covariates: the reinforced doubly adaptive biased coin design ⋮ Response-adaptive designs for continuous outcomes ⋮ On a two-treatment adaptive allocation rule for continuous response ⋮ A General Multi-Treatment Adaptive Design for Multivariate Responses ⋮ A general adaptive allocation design for continuous responses in the presence of covariates ⋮ Multi-treatment optimal response-adaptive designs for phase III clinical trials ⋮ Marginal Regression for Binary Longitudinal Data in Adaptive Clinical Trials ⋮ A Bayesian adaptive design for two-stage clinical trials with survival data ⋮ Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint ⋮ Contribution of Milton Sobel in Selection Problem Following Ethical Allocation ⋮ Kernel-Based Response-Adaptive Design for Continuous Responses ⋮ Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes ⋮ An adaptive allocation design for circular treatment outcome ⋮ A covariate-adjusted response-adaptive allocation for a general class of continuous responses ⋮ Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker ⋮ On the almost sure convergence of adaptive allocation procedures ⋮ A response-adaptive design in crossover trial
This page was built for publication: Adaptive designs for normal responses with prognostic factors